Corbevax vaccine Current Affairs, GK & News

CORBEVAX’ gets DCGI approval for Clinical trials

The Drug Controller General of India (DCGI) gave approval to another indigenous COVID-19 vaccine candidate called CORBEVAX for two clinical trials. Highlights Vaccine maker Biological E received approval to conduct phase two and three clinical trials on children between five to eighteen years of age. Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council ..

Month: 

Category: 

Topics: 

Vaccine Prices capped for Private Hospitals

Union Health Ministry has capped the price for administration of Covid-19 vaccines in private hospitals. Key Points Maximum price for Covaxin was fixed at Rs 1,400. Covishield will cost Rs 780 per dose, while Sputnik V vaccine will cost Rs 1,145 per dose. Strict action will be taken against private vaccination centres for overcharging. Apart ..

Month: 

Category: 

Topics: